ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
Volume 0.65M
Average 1.06M
ADRX Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Revenue history
Currency unavailable · from the income statement
No Revenue data reported for this period type.
Revenue vs competitors
How ADRX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $79.76M USD | +131.1% | +72.3% | |
| LTM Mar 2026 | $71.8M USD | -31.6% | +127.1% | |
| LTM Mar 2026 | $45.35M USD | -66.4% | -31.1% | |
| LTM Mar 2026 | $32.08M USD | -83.2% | +145.9% | |
| FY2025 | $18.62M USD | — | — | |
| LTM Mar 2026 | €13.44M EUR | -29.2% | +62.0% | |
| LTM Mar 2026 | $4.03M USD | +4.9% | — | |
| LTM Mar 2026 | $921.49K USD | — | -68.4% | |
| LTM Mar 2026 | $0 USD | — | — | |
ADRXADARx Pharmaceuticals, Inc. | — | — | — | — |
| Peer median (excluding ADRX) | — | -30.4% | +67.1% | |
Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRX
Intrinsic Alpha fair value
Locked
Current Price
$12.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.